Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII) -- Ignore unavailable to you. Want to Upgrade?

To: Apache Indian who wrote (449)	2/18/1999 3:58:00 PM
From: sim1	Respond to of 1494

Thanks for sharing. <eom>

To: Apache Indian who wrote (449)	2/18/1999 9:25:00 PM
From: Dr. John M. de Castro	Read Replies (1) \| Respond to of 1494

What a great letter. Thanks for sharing it. Paul Freiman is a straight shooter. He doesn't make hollow statements. So, I believe that the contents of this letter are 100% accurate. I am particularly struck by the statement "Merz and NTI are negotiating a major global marketing agreement with a large pharmaceutical company" What strikes me is the use of the singular. NTI was negotiating with at least 6 different companies. The use of the singular tells me that the negotiations are very far along. I wasn't aware that thing have advanced this far. This is great news. Merz is a very conservative secretive company that I am sure have made the negotiations slow and detailed. The fact that Paul Freiman is talking about a few months to sign the deal is very important. We shareholders should be very grateful to Freiman that he has kept this company afloat in a very difficult period without entering into some kind of off-shore mega dilution deal or a dreaded floorless convertible. The float is still very small. As such, the value of our shares has been protected. Once, a deal is penned, with the miniscule float, IMHO NTI will soar. John de C

To: Apache Indian who wrote (449)	2/19/1999 12:10:00 AM
From: BRAVEHEART	Read Replies (1) \| Respond to of 1494

Hi Apache Indian, Based on your post I started to acquire another 10,000 shares. I just checked and found that I picked up 3,000 at the end of today. While I will stress until the company finalizes some sort of inhouse/long term investor/bridge financing. I must stick with my initial plan to stay the course. I know the markets will react to a Global partner. On one hand I was thinking. Sell some and wait for the inhouse/ investor financing and then buy back at a marginally higher price to avoid the risk. I then think what if the inhouse financing is announced along with a global partnership for Memantine much in the same manner as the MERZ release was handled less than a year ago. I would miss out on the return to Valuation. So I look to your letter. I look to P. Friemans impeccable past. I look to my calls to the company. I look to the product potential and lower risk profile. I look to MERZ as a security blanket. I look to the quality of this thread. I too am comforted. Thanks Apache Indian, Jeffrey Allen